Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Survey Of 6,000 Kratom Users Shows No Evidence Of Epidemic Or Abuse Justifying DEA Push To Ban Coffee-Like Herb


News provided by

Pain News Network, Washington DC

Sep 20, 2016, 01:40 ET

Share this article

Share toX

Share this article

Share toX

WASHINGTON, Sept. 20, 2016 /PRNewswire-USNewswire/ -- Nine out of 10 respondents in the largest survey conducted to date of kratom users believe that the coffee-like herb is effective for dealing with joint and muscle comfort and related problems, according to the findings released today by the Pain News Network (PNN) at http://www.painnewsnetwork.org/kratom-survey/.

The survey of 6,150 kratom users was conducted between the August 30th announcement by the US Drug Enforcement Administration (DEA) of a proposed ban on kratom and the end of last week.  With the support of the American Kratom Association (AKA), PNN promoted participation in the survey to its own readers and the broader public via social media channels.  The poll of kratom users involves a sample that is at least 10 times larger than any previous such survey. PNN maintained full editorial control of the survey questions and the presentation of the findings. 

Other key survey findings include the following:

  • The top three reasons kratom user said they use the herb are:  chronic or acute pain (51 percent); anxiety (14 percent); and treatment of opioid addiction or dependence (9 percent). Important note:  AKA and the Botanical Education Alliance (which joined PNN and AKA in releasing the findings) make no medical-related claims for kratom in connection with the survey published today by the Pain News Network.
  • For those using kratom to deal with pain, the five most common issues are:  spine or back (38 percent); other (15 percent); an injury (11 percent); fibromyalgia (9 percent); and osteoarthritis (3 percent).
  • 66 percent of kratom users said that a ban on kratom would result in them being "more likely to be addicted and overdose on other substances."
  • More than one out of four kratom users (27 percent) said they would still use kratom even if it is banned by the DEA an 43 percent indicated they are unsure what they would do.
  • 98 percent of kratom users do not believe that it is a harmful or dangerous substance.
  • 75 percent said it is not possible to get "high" from kratom.
  • 95 percent said that making kratom illegal would be harmful or society.

Susan Ash, director, American Kratom Association, said: "In declaring war on kratom, the DEA never took the time to actually look at what is happening with this natural herb.  They never took the time to talk to or to survey kratom users.  If they had, they would have learned of the very positive picture that emerges from the Pain News Network survey.  There is no kratom epidemic or crisis. This is a natural herb in the coffee family that people are using in their lives in a variety of positive ways.  The DEA war on kratom is not justified by the facts, it is not based on scientific data, and it needs to stop now."

Travis Lowin, executive director, Botanical Education Alliance, said: "We must unite to bring the truth about Kratom to regulators and Congress. We cannot let the DEA get away with scheduling an herb that millions of Americans use safely to support their overall health and wellbeing. The DEA has failed Americans in its efforts to combat the opioid epidemic and targeting Kratom will make the situation worse. Our organization and Americans nationwide are only demanding that we receive due process and sensible regulation. Veterans, seniors, and other kratom customers in the US should not have to pay the price for the DEA failing to play by the rules."

Dr. Addie Davis, a resident physician in emergency medicine in California, said: "The CDC has actually recognized the use of prescription narcotics and particularly the number of deaths resulting from their use as a national epidemic causing thousands of deaths every year. In 2014 there were over 14,000 resulting from narcotic abuse. On the flip side, there is kratom. Kratom is an herb that is not very well known but I happen to know plenty of people who use it.  It is not new. It has many uses, some of which include managing fatigue, depression and anxiety. Most pertinent to my career, however, is kratom's ability to help people manage chronic pain. I have seen many people wean themselves off of opiates successfully with the aid of kratom. In contrast to prescription narcotics, kratom is not dangerous and is non-habit forming. Kratom is not an opiate. Its active alkaloids work on mu-opioid, serotonin and dopaminergic receptors in the brain.  It cannot cause respiratory depression, unlike prescription narcotics.  Kratom has clear health benefits and it is used by thousands of people in this country every day.  If kratom is scheduled as a schedule I substance, many of the people who use it for pain control will likely return to using prescription narcotics. This will result in thousands of deaths annually."

Pat Anson, founder and editor, Pain News Network, said: "Our survey provides the biggest and clearest overall picture to date of what is actually going on in the world of kratom use. What we see here are people with real issues and concerns who will be in a tough spot if the DEA bans kratom use. The survey findings dispel the myth that kratom is used recreationally like marijuana by people who only want to get high. The vast majority say they use kratom solely to treat and manage their medical conditions."

The DEA is now seeking to ban kratom, or Mitragyna speciose, a tree in the coffee family native to Southeast Asia. Kratom leaves have been consumed in countries like Thailand and Malaysia for over 500 years. The herb is now available in the U.S. just like other herbal supplements.

Kratom is not an opiate. Many studies have shown kratom to have positive medicinal benefits. Kratom is legal in 44 states. The Florida Department of Law Enforcement released a December 2015 report that found: "Kratom does not currently constitute a significant risk to the safety and welfare of Florida residents." Nonetheless, on August 31, 2016, the DEA announced its intention to place kratom into Schedule I of the Controlled Substances Act in order to avoid a supposed "imminent hazard to public safety," which, in reality, does not exist. In truth, kratom has never been present alone in a single documented death and is as about as habit-forming as the coffee to which it is related. By contrast, pharmaceutical drugs are one of the leading causes of death in this country, killing one American every 19 minutes. Prescription opiate pain killers account for more than 475,000 emergency room visits annually.

For more information about concerns raised about the DEA war on kratom, go to
http://www.painnewsnetwork.org/stories/2016/9/13/kratom-supporters-rally-at-white-house
and http://www.snopes.com/kratom-banned-by-the-dea/.

ABOUT THE GROUPS

Pain News Network is a 501(c)(3) non-profit, independent online news source for information and commentary about chronic pain and pain management.  The Network's mission is to raise awareness about chronic pain, and to connect and educate pain sufferers, caregivers, healthcare providers and the public about the pain experience.  http://www.painnewsnetwork.org/overview/

The America Kratom Association (AKA), a consumer-based non-profit, is here to set the record straight, giving voice to the suffering and our rights to possess and consume kratom. AKA represents tens of thousands of Americans; each with a unique story to tell about the virtues of kratom and its positive effects on our lives. From Lyme Disease to Post Traumatic Stress Disorder and even addiction, kratom can help offer relief.  www.americankratom.org

The Botanical Education Alliance (BEA) is an organization dedicated to educating consumers, lawmakers, law enforcement, and the media about safe and therapeutic natural supplements including Mitragyna speciosa, also known as Kratom. BEA's mission is to increase understanding in order to influence public policy and protect natural supplements. The vision of the Alliance is to create a society where every adult has the right to access safe and effective natural supplements.  www.botanical-education.org/

CAN'T PARTICIPATE?:  A streaming audio replay of this news event and full survey results will be available as of 3 p.m. EDT/noon PDT on September 20, 2016 at http://www.painnewsnetwork.org/kratom-survey/. 

SOURCE Pain News Network, Washington DC

Related Links

http://www.painnewsnetwork.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.